Healthcare provider profile · identity verified

Christopher John Thompson, MD

Family Practice · SAINT CLOUD, MN · NPI 1770757429

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	392	105
Losartan Potassium	Losartan Potassium	316	78
Amlodipine Besylate	Amlodipine Besylate	231	53
Metoprolol Succinate	Metoprolol Succinate	211	51
Omeprazole	Omeprazole	190	49
Lisinopril	Lisinopril	177	52
Levothyroxine Sodium	Levothyroxine Sodium	160	29
Tamsulosin Hcl	Tamsulosin Hcl	160	37
Hydrochlorothiazide	Hydrochlorothiazide	147	40
Simvastatin	Simvastatin	129	36
Allopurinol	Allopurinol	110	23
Warfarin Sodium	Warfarin Sodium	108	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	27
Rosuvastatin Calcium	Rosuvastatin Calcium	95	26
Famotidine	Famotidine	85	26
Metformin Hcl Er	Metformin Hcl	82	25
Pantoprazole Sodium	Pantoprazole Sodium	71	19
Fluticasone Propionate	Fluticasone Propionate	65	19
Furosemide	Furosemide	63	14
Gabapentin	Gabapentin	63	19
Citalopram Hbr	Citalopram Hydrobromide	58	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	15
Spironolactone	Spironolactone	53	16
Metoprolol Tartrate	Metoprolol Tartrate	48	13
Pravastatin Sodium	Pravastatin Sodium	48	13
Carvedilol	Carvedilol	47	11
Metformin Hcl	Metformin Hcl	45	14
Duloxetine Hcl	Duloxetine Hcl	44	11
Sertraline Hcl	Sertraline Hcl	44	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Potassium Chloride	Potassium Chloride	40	suppressed
Prednisone	Prednisone	37	suppressed
Eliquis	Apixaban	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Divalproex Sodium	Divalproex Sodium	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	27	suppressed
Torsemide	Torsemide	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Finasteride	Finasteride	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	13
Bupropion Xl	Bupropion Hcl	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Glipizide Er	Glipizide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Ozempic	Semaglutide	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error